Schulze's study showed that high MYC Targets v1 enrichment scores were associated with high mutation load, increased infiltration of pro-and anticancerous immune cells, tumor aggressiveness, and poor prognosis of ER-positive cancer [30]. Here, MYC is linked to neoplasm.